Qube Research & Technologies LTD Axonics, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXNX
# of Institutions
228Shares Held
41.7MCall Options Held
50.2KPut Options Held
135K-
Vanguard Group Inc Valley Forge, PA5.06MShares$357 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$306 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.18MShares$153 Million6.99% of portfolio
-
Fil LTD Hamilton, D02.04MShares$144 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$125 Million2.93% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.46B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...